Literature DB >> 4980433

Interaction of human peripheral lymphocytes and granulocytes in the migration-inhibition reaction.

M Soborg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4980433

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  8 in total

1.  In vitro studies of delayed-type hypersensitivity. The time course of the primary immunological reaction in individual rats determined by macrophage spreading inhibition.

Authors:  B Veselic; D Dekaris; K M Hrsak
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

2.  Cellular immunity to breast carcinoma and malignant melanoma.

Authors:  A J Cochran; R M Mackie; C E Thomas; R M Grant; D E Cameron-Mowat; W G Spilg
Journal:  Br J Cancer Suppl       Date:  1973-08

3.  Mechanism of buffy coat migration inhibition test.

Authors:  M D Lockshin; J Waxman; M W Jenkins
Journal:  Experientia       Date:  1973-03-15

4.  Evaluation of the leucocyte migration test as a measure of delayed hypersensitivty in man. Suppression of migration inhibition by puromycin.

Authors:  C G Mitchell; M G Smith; P L Golding; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

5.  In vitro delayed hypersensitivity in normal and hyporeactive patients.

Authors:  M D Lockshin; S Bombardieri
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

6.  The leucocyte migration technique as an assay of presensitization to human transplantation antigens.

Authors:  A J D'Apice; B D Tait; P J Morris
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

7.  Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.

Authors:  B M Jones
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

8.  A micro-method for peripheral leucocyte migration in tuberculin sensitivity.

Authors:  K Federlin; R N Maini; A S Russell; D C Dumonde
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.